Cargando…
Treatment of hereditary angioedema—single or multiple pathways to the rescue
Hereditary angioedema (HAE) is a rare disease caused by mutations in the SERPING1 gene. This results in deficient or dysfunctional C1 esterase inhibitor (C1-INH) and affects multiple proteases involved in the complement, contact-system, coagulation, and fibrinolytic pathways. Current options for the...
Autores principales: | Valerieva, Anna, Longhurst, Hilary J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510393/ https://www.ncbi.nlm.nih.gov/pubmed/36172291 http://dx.doi.org/10.3389/falgy.2022.952233 |
Ejemplares similares
-
Editorial: C1 inhibitor deficiency and angioedema
por: Farkas, Henriette, et al.
Publicado: (2022) -
Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022) -
The complex role of kininogens in hereditary angioedema
por: Kaplan, Allen P., et al.
Publicado: (2022) -
A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable
por: Longhurst, Hilary J, et al.
Publicado: (2023) -
Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor
por: Gabriel, Natalia, et al.
Publicado: (2022)